Based on these data, we deduced that TP73 also exerts disease-modifying effects in the presence of a combination with other rare variants in the known causative genes for ALS, mainly in accelerating the age at onset, rather than shortening survival time. This evidence concerns the gene TP73 and amyotrophic lateral sclerosis.